Home

NEWBORN SCREENING

Photo courtesy of © UNICEF/UN013396/Khonje
MIKE RAMIREZ: michael-ramirez@uiowa.edu

The Iowa Newborn Screening Program was selected for the NewSTEPs 360 program, a 20-state cohort aimed at improving timeliness in newborn screening. NewSTEPs 360 is a collaboration between the Association of Public Health Laboratories and the Colorado School of Public Health.

The Iowa Newborn Screening Program is among the fastest in the nation in delivering test results to health care providers, creating a greater opportunity for interventions that can improve outcomes for babies affected by a genetic disorder.

The Newborn Screening section identifies infants at risk for more than 50 inherited conditions by testing a small blood spot obtained from a simple heel stick shortly after birth. At this age, most infants with an inherited condition show no obvious signs of disease. However, with special tests, the Iowa Newborn Screening Program can identify an infant who may be at risk and alert the doctor and caregivers of the need for immediate medical treatment for the infant.

With early diagnosis and medical treatment, complications from these serious, but uncommon, conditions can usually be prevented. The goal is to identify the disorder before the disorder causes damaging health effects.

The Iowa Newborn Screening Program is part of the Iowa Department of Public Health, and is a collaborative effort between the IDPH, the State Hygienic Laboratory, the University of Iowa Stead Family Children’s Hospital, Central Delivery Service of Iowa, and Iowa birthing and newborn care providers. In addition to Iowa, the Hygienic Laboratory provides newborn screening testing for North Dakota and South Dakota.

HIGHLIGHTS

  • Integrated screening for Severe Combined Immunodeficiency (SCID) into the South Dakota newborn blood spot screening panel on Sept 1, 2015. SCID is the first condition to directly use a DNA target as the marker for the disorder and the first condition identified through newborn screening for which a cure is available.

  • Gave a “Best Practices in Newborn Screening” presentation to health care professionals representing seven hospitals in northwest Iowa.

  • Chosen to be part of the Collaborative Improvement and Innovation Network (CoIIN) project on specimen submission timeliness in newborn screening. The goal is to ensure all specimens are received for testing within 60 hours of birth.

  • Hosted the “Iowa CoIIN for Timeliness in Newborn Screening” webinar and made onsite visits to several hospitals across Iowa to educate nursery and lab staff regarding best practices for bloodspot collection and to discuss timeliness goals.

  • Iowa lab and clinical staff gave the “Newborn Screening Timeliness” presentation at the North Dakota Newborn Screening Conference, which was attended by more than 100 health care professionals.

BLOOD SPOT SCREENING PANEL

BIOTINDASE DEFICIENCY
GALACTOSEMIA
HEMOGLOBINOPATHIES
CYSTIC FIBROSIS
CONGENITAL HYPOTHYROIDISM
CONGENITAL ADRENAL HYPERPLASIA
AMINO ACID DISORDERS
FATTY ACID OXIDATION DISORDERS
ORGANIC ACID DISORDERS
SEVERE COMBINED IMMUNODEFICIENCY

SCREENING VOLUME
IOWA
331,660
NORTH DAKOTA
95,878
SOUTH DAKOTA
106,964
SPECIMENS RECEIVED
IOWA
41,509
NORTH DAKOTA
13,734
SOUTH DAKOTA
13,695

Other Units in Disease Control


The Office of the Director consists of 10 key functional units that enable the State Hygienic Laboratory to achieve its statutory charge set forth in the Iowa Administrative Code.


The primary mission of the Disease Control Division is to test human specimens, food and water for diseases of public health significance to protect the citizens of Iowa.


The Environmental Health Division monitors drinking water, wastewater, air, soil and food for contaminants of potential environmental and public health concern.


The Division of Administration and Finance is responsible for the management of the business practices, all Hygienic Laboratory facilities, and pre/post testing support.